Examine evidence linking obstructive airway conditions and inflammatory bowel diseases through a unified gut–lung axis systematic review and meta-analysis.
Key Takeaways
- Global prevalence of IBD currently ranges from 0.3% to 1%, with a steady increase observed ( 1 , 2 )
- Early identification of modifiable risk factors is thus critical to delaying disease onset
- COPD is characterized by an incompletely reversible airflow limitation